High mobility group box 1 protein interacts with multiple Toll-like receptors

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 3, 2006, Pages

  Jong, Sung Park ^a   Gamboni Robertson, Fabia ^a   He, Qianbin ^a   Svetkauskaite, Daiva ^a   Kim, Jae Yeol ^a   Strassheim, Derek ^a   Sohn, Jang Won ^a   Yamada, Shingo ^b   Maruyama, Ikuro ^c   Banerjee, Anirban ^a   Ishizaka, Akitoshi ^d   Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SHINO TEST CORPORATION   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Fluorescence resonance energy transfer; Receptor of advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; RAGE PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TUMOR ANTIGEN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; ANTIGENS, NEOPLASM; CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33645461206     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00401.2005     Document Type: Article

References (47)

1. Abraham E, Arcaroli J, Carmody A, Wang H, and Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 165: 2950-2954, 2000.
2. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, and Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570, 2000.
3. Boonyaratanakornkit V, Melvin V, Prendergast P, Altmann M, Ronfani L, Bianchi ME, Taraseviciene L, Nordeen SK, Allegretto EA, and Edwards DP. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 18: 4471-4487, 1998.
4. Cardullo RA and Parpura V. Fluorescence resonance energy transfer microscopy: theory and instrumentation. Methods Cell Biol 72: 415-430, 2003.
5. Chow JC, Young DW, Golenbock DT, Christ WJ, and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274: 10689-10692, 1999.
6. Clegg RM, Murchie AI, Zechel A, and Lilley DM. Observing the helical geometry of double-stranded DNA in solution by fluorescence resonance energy transfer. Proc Natl Acad Sci USA 90: 2994-2998, 1993.
7. Costello E, Saudan P, Winocour E, Pizer L, and Beard P. High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression. EMBO J 16: 5943-5954, 1997.
8. Czura CJ, Wang H, and Tracey KJ. Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 7: 315-321, 2001.
9. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, Arrigoni G, and Bianchi ME. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152: 1197-1206, 2001.
10. Dintilhac A and Bernues J. HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J Biol Chem 277: 7021-7028, 2002.
11. Ferrari S, Finelli P, Rocchi M, and Bianchi ME. The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 35: 367-371, 1996.
12. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, and Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660, 2003.
13. Gordon GW, Berry G, Liang XH, Levine B, and Herman B. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys J 74: 2702-2713, 1998.
14. Herman B. Resonance energy transfer microscopy. Methods Cell Biol 30: 219-243, 1989.
15. Hirschfeld M, Ma Y, Weis JH, Vogel SN, and Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 165: 618-622, 2000.
16. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, and Schmidt AM. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system. J Biol Chem 270: 25752-25761, 1995.
17. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, and Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62: 4805-4811, 2002.
18. Huttunen HJ, Fages C, and Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274: 19919-19924, 1999.
19. Irie T, Muta T, and Takeshige K. TAK1 mediates an activation signal from Toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide- stimulated macrophages. FEBS Lett 467: 160-164, 2000.
20. Jares-Erijman EA and Jovin TM. FRET imaging. Nat Biotechnol 21: 1387-1395, 2003.
21. Jayaraman L, Moorthy NC, Murthy KG, Manley JL, Bustin M, and Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12: 462-472, 1998.
22. Jiang Q, Akashi S, Miyake K, and Petty HR. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. J Immunol 165: 3541-3544, 2000.
23. Klostermeier D and Millar DP. Time-resolved fluorescence resonance energy transfer: a versatile tool for the analysis of nucleic acids. Biopolymers 61: 159-179, 2001.
24. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, and Espevik T. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277: 47834-47843, 2002.
25. Millar DP. Time-resolved fluorescence methods for analysis of DNA-protein interactions. Methods Enzymol 323: 442-459, 2000.
26. Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, and Schmidt AM. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98: 1088-1094, 1996.
27. Nishitani C, Mitsuzawa H, Hyakushima N, Sano H, Matsushima N, and Kuroki Y. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2. Biochem Biophys Res Commun 328: 586-590, 2005.
28. Onate SA, Prendergast P, Wagner JP, Nissen M, Reeves R, Pettijohn DE, and Edwards DP. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 14: 3376-3391, 1994.
29. Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, Cossu G, and Bianchi ME. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 164: 441-449, 2004.
30. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, and Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284: C870-C879, 2003.
31. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, and Abraham E. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370-7377, 2004.
32. Passalacqua M, Zicca A, Sparatore B, Patrone M, Melloni E, and Pontremoli S. Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. FEBS Lett 400: 275-279, 1997.
33. Sanders C. A method for the fractionation of the high-mobility-group non-histone chromosomal proteins. Biochem Biophys Res Commun 78: 1034-1042, 1977.
34. Scaffidi P, Misteli T, and Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
35. Schwartz MD, Repine JE, and Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 12: 434-440, 1995.
36. Selvin PR. The renaissance of fluorescence resonance energy transfer. Nat Struct Biol 7: 730-734, 2000.
37. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189: 1777-1782, 1999.
38. Sparatore B, Pedrazzi M, Passalacqua M, Gaggero D, Patrone M, Pontremoli S, and Melloni E. Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem J 363: 529-535, 2002.
39. Szollosi J, Nagy P, Sebestyen Z, Damjanovicha S, Park JW, and Matyus L. Applications of fluorescence resonance energy transfer for mapping biological membranes. J Biotechnol 82: 251-266, 2002.
40. Takeuchi O and Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1: 625-635, 2001.
41. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, and Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-981, 2003.
42. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, and Palmblad JE. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 254: 375-385, 2003.
43. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, and Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143, 2005.
44. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, and Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
45. Wen L, Huang JK, Johnson BH, and Reeck GR. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 17: 1197-1214, 1989.
46. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, and Tracey KJ. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 101: 296-301, 2004.
47. Zwilling S, Konig H, and Wirth T. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J 14: 1198-1208, 1995.